IRIS
CRIMI, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.068
AS - Asia 4.560
EU - Europa 2.520
SA - Sud America 569
AF - Africa 442
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.168
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.934
SG - Singapore 1.899
CN - Cina 1.491
RU - Federazione Russa 982
IT - Italia 704
BR - Brasile 470
KR - Corea 465
VN - Vietnam 238
IE - Irlanda 235
FR - Francia 179
CI - Costa d'Avorio 159
BD - Bangladesh 124
NG - Nigeria 97
GB - Regno Unito 84
CA - Canada 77
IN - India 76
FI - Finlandia 54
BJ - Benin 53
NL - Olanda 50
DE - Germania 46
AR - Argentina 41
SN - Senegal 41
MX - Messico 36
ZA - Sudafrica 34
JP - Giappone 33
IQ - Iraq 32
UA - Ucraina 32
PL - Polonia 29
TR - Turchia 28
KE - Kenya 26
IR - Iran 25
SE - Svezia 25
ES - Italia 23
HK - Hong Kong 22
EC - Ecuador 14
PK - Pakistan 14
CO - Colombia 13
AT - Austria 12
GR - Grecia 11
ID - Indonesia 11
MA - Marocco 11
MY - Malesia 11
PH - Filippine 11
AE - Emirati Arabi Uniti 10
LT - Lituania 10
VE - Venezuela 10
JO - Giordania 9
SA - Arabia Saudita 9
AZ - Azerbaigian 7
CH - Svizzera 7
UZ - Uzbekistan 7
BE - Belgio 6
CL - Cile 6
ET - Etiopia 6
NP - Nepal 6
PY - Paraguay 6
IL - Israele 5
KZ - Kazakistan 5
AU - Australia 4
DZ - Algeria 4
EG - Egitto 4
GT - Guatemala 4
HU - Ungheria 4
OM - Oman 4
PE - Perù 4
PT - Portogallo 4
TN - Tunisia 4
BG - Bulgaria 3
DO - Repubblica Dominicana 3
LB - Libano 3
PA - Panama 3
PS - Palestinian Territory 3
RO - Romania 3
SI - Slovenia 3
TT - Trinidad e Tobago 3
BO - Bolivia 2
CR - Costa Rica 2
DK - Danimarca 2
EU - Europa 2
HR - Croazia 2
KG - Kirghizistan 2
NI - Nicaragua 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
JM - Giamaica 1
KW - Kuwait 1
LV - Lettonia 1
LY - Libia 1
Totale 13.158
Salva come PNG Salva come JPEG
Città #
Dallas 1.280
Singapore 1.129
Hefei 808
Santa Clara 776
San Jose 507
Seoul 462
Ashburn 379
Moscow 374
Dublin 235
Chicago 190
Boardman 176
Los Angeles 174
Abidjan 159
Beijing 154
Lauterbourg 151
Council Bluffs 113
Chandler 100
Catania 89
New York 83
Ho Chi Minh City 79
Civitanova Marche 65
Hanoi 58
Lagos 58
São Paulo 58
Buffalo 56
Milan 56
Cotonou 53
Rome 46
Palermo 45
Lappeenranta 44
Dakar 41
Abuja 35
Jacksonville 35
Orem 35
Johannesburg 27
Amsterdam 25
Tokyo 25
Montreal 24
Toronto 24
Warsaw 24
Brooklyn 23
Pune 22
Tehran 22
Seattle 21
Atlanta 20
Lawrence 19
Andover 18
Cambridge 18
Rio de Janeiro 17
Hong Kong 16
Phoenix 16
Chennai 15
Poplar 15
Des Moines 14
Manchester 14
Frankfurt am Main 13
Nanjing 13
Ankara 12
Naples 12
San Francisco 12
Stockholm 12
Denver 11
Kochi 11
Bari 10
Boston 10
Da Nang 10
Houston 10
Messina 10
Salvador 10
Bologna 9
Bremen 9
Dhaka 9
Dong Ket 9
Giarre 9
London 9
Belo Horizonte 8
Mexico City 8
Reggio Emilia 8
Secaucus 8
Wilmington 8
Amman 7
Baghdad 7
Brasília 7
Campinas 7
Fortaleza 7
Haiphong 7
Helsinki 7
Mumbai 7
Munich 7
Paris 7
Ribeirão Preto 7
Rimini 7
Shenyang 7
Turin 7
Aci Catena 6
Assago 6
Corbetta 6
Gravina di Catania 6
Hải Dương 6
Lahore 6
Totale 8.906
Salva come PNG Salva come JPEG
Nome #
Practice of oxygenation and respiratory support during fibreoptic bronchoscopy: the OxyFOB study protocol 396
Acute and long-term management of severe bronchiectasis with high flow nasal therapy: A case report 146
Computational Analyses of YY1 and Its Target RKIP Reveal Their Diagnostic and Prognostic Roles in Lung Cancer 143
Acute additive effect of montelukast and beclomethasone on AMP induced bronchoconstriction 138
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study 136
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 133
Anti-inflammatory role of vitamin D in muscle dysfunctions of patients with chronic obstructive pulmonary disease: a comprehensive review 133
Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study 130
Rugarli. Medicina interna sistematica 129
Long-Term Domiciliary High-Flow Nasal Therapy in Patients with Bronchiectasis: A Preliminary Retrospective Observational Case-Control Study 126
Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study 126
State of the art in interstitial pneumonia with autoimmune features: A systematic review on retrospective studies and suggestions for further advances 124
Type 2-High Severe Asthma with and without Bronchiectasis: A Prospective Observational Multicentre Study 123
Bronchodilator response as a marker of poor asthma control 122
Protective effect of Resveratrol on TGF-beta-induced lung fibroblast differentiation 121
Asthma severity: the patient’s point of view 120
Depemokimab, the first ultra-long-acting anti-IL-5 monoclonal antibody for severe eosinophilic asthma 119
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial 117
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience 117
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps 115
Use of ketamine in patients with refractory severe asthma exacerbations: systematic review of prospective studies 112
Benralizumab: from tissue distribution to eosinophilic cytotoxicity up to potential immunoregulation 110
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma treated with Mepolizumab: The REMI-M study 110
Higher serum levels of periostin and the risk of exacerbations in moderate asthmatics 108
Diastolic Function and Positive Airway Pressure: More Research Is Warranted 107
A European survey of Non- Invasive Ventilation (NIV) 107
Adherence to omalizumab: A multicenter "real-world" study 107
Utility of ultrasound assessment of diaphragmatic function before and after pulmonary rehabilitation in COPD patients 106
Reliability and usefulness of a rapid IgM‐IgG antibody test for the diagnosis of SARS-CoV-2 infection: A preliminary report 105
Continuous vs intermittent Non-Invasive blood pressure MONitoring in preventing postoperative organ failure (niMON): study protocol for an open-label, multicenter randomized trial 104
Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission 103
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super‐Response and Remission With Mepolizumab 102
Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis 101
Prevalence and determinants of co-morbidities in patients with obstructive apnea and chronic obstructive pulmonary disease 101
Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort 100
Biologics as well as inhaled anti-asthmatic therapy achieve clinical remission: Evidence from the Severe Asthma Network in Italy (SANI) 99
Eosinophilic Bronchiectasis: Prevalence, Severity, and Associated Features—A Cohort Study 99
Impact of asthma on bronchiectasis severity and risk of exacerbations 98
Intermittent abdominal pressure ventilation management in neuromuscular diseases: a Delphi panel Consensus 97
A Key to Unlocking the Mysteries of COVID-19 Pulmonary Sequelae: Are We There? 97
Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study 97
Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13 97
Personalized Medicine in Asthma: Current Approach and Future Perspectives 96
Mutual Interaction Between Human Lung Fibroblasts And T LymphocyteS 96
Resumption of respiratory outpatient services in the COVID-19 era: Experience from Southern Italy 96
Diagnostic delay in bronchiectasis: an Italian perspective 95
Are we overlooking the lung function in the definition of severe asthma remission? 95
Interaction between human lung fibroblasts and T-lymphocytes prevents activation of CD4+ cells 95
Exhaled breath condensate cysteinyl leukotrienes (cys-LTs) in gastroesophageal reflux disease-related asthma 93
The Link between Asthma and Bronchiectasis: State of the Art 92
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis 91
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study 90
Airway hyperresponsiveness with chest strapping: A matter of heterogeneity or reduced lung volume? 89
Effects of high-flow nasal therapy on swallowing function: a scoping review 88
Long-Term High-Flow Nasal Therapy in Patients with Bronchiectasis of Different Severity: A Retrospective Cohort Study 88
Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis 88
Airway hyperresponsiveness with chest strapping: effects of heterogeneity and reduced lung volume 87
“The Kafka’s Disease” 87
Profiling blood hypereosinophilia in patients on dupilumab treatment for respiratory conditions: a real-life snapshot 85
Biologics in severe asthma 85
Is the Power Spectrum of Electromyography Signal a Feasible Tool to Estimate Muscle Fiber Composition in Patients with COPD? 84
Point-of-care blood eosinophil count in a severe asthma clinic setting 83
Impact of Long-Term High-Flow Nasal Therapy on Mucus Plugs in Patients with Bronchiectasis 82
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 81
Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression 81
Tezepelumab for asthma 81
A pragmatic, open-label, multi-center, randomized controlled clinical trial on the rotational use of interfaces vs standard of care in patients treated with noninvasive positive pressure ventilation for acute hypercapnic respiratory failure: the ROTAtional-USE of interface STUDY (ROTA-USE STUDY) 81
Monoclonal Antibodies Targeting Alarmins: A New Perspective for Biological Therapies of Severe Asthma 80
Exhaled breath condensate pH and cysteinyl leukotriens in patients with chronic cough secondary to acid gastroesophageal reflux 80
Prolonged respiratory failure: when doctor and family connect, the patient wins 79
Comparability of asthma control test scores between self and physician-administered test 79
Effects of High-Flow Nasal Cannula on Right Heart Dysfunction in Patients with Acute-on-Chronic Respiratory Failure and Pulmonary Hypertension 78
Effectiveness of an educational intervention on different types of errors ­occurring during inhaler therapy use in COPD patients during a ­Pulmonary Rehabilitation Program 77
Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life Perspective 77
Performance of EasyBreath Decathlon Snorkeling mask for delivering continuous positive airway pressure 77
A new gambler at the table of management of COVID-19 associated acute respiratory failure. Changing position to do it better? 77
Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients 76
Bronchial reversibility testing: an index of poorly controlled asthma 76
Impact of chronic obstructive pulmonary disease on passive viscoelastic components of the musculoarticular system 76
Noninvasive respiratory support in acute hypoxemic respiratory failure associated with COVID-19 and other viral infections 75
ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up 74
Indacaterol/glycopyrronium/mometasone fixed dose combination for uncontrolled asthma 73
Domiciliary Non-invasive Ventilation in COPD: An International Survey of Indications and Practices 73
Fully covered self-expandable metal stent (SEMS) in tracheo-bronchial disorders: clinical experience 72
Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program 72
The accuracy of the HemoCue WBC DIFF in assessing blood eosinophils depends on the clinical setting and medical condition 72
Effect of high-flow nasal therapy on dyspnea, comfort, and respiratory rate 71
Ultrasound-guided placement of long peripheral cannula in children with cystic fibrosis 70
Long-term home noninvasive ventilation (LTHNIV) in restrictive thoracic diseases: The Italian snapshot 69
Can humidified high flow reverse mucus plugging? 69
Uneven use of noninvasive ventilation in acute respiratory failure in Europe 68
Effectiveness of Mepolizumab on Mucus Plug Reduction and Clinical Outcomes in Severe Eosinophilic Asthma: A Prospective Observational Study 68
Secretion management in patients with ineffective airway clearance with non-invasive mechanical ventilation use: Expert guidance for clinical practice 68
Challenges for the female health-care workers during the COVID-19 pandemic: the need for protection beyond the mask 68
Incidence and diagnosis of HIT in patients undergoing thoracoabdominal aortic aneurysm (TAA) repair 67
High-Flow Nasal Therapy in Acute and Chronic Respiratory Failure: Past, Present, and Future 67
Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma 67
Novel Biological Therapies for Severe Asthma Endotypes 65
Short-Term Evaluation of Dupilumab Effects in Patients with Severe Asthma and Nasal Polyposis 65
Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19? 64
Totale 9.679
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.671
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.671
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 0 0 10
2021/2022126 12 20 0 2 17 0 20 2 14 2 3 34
2022/2023623 19 11 8 44 23 50 47 111 243 19 19 29
2023/2024678 24 77 39 58 29 122 16 67 7 34 132 73
2024/20253.340 67 445 223 108 605 363 131 83 221 300 302 492
2025/20268.405 581 1.105 1.493 459 1.027 1.266 856 215 375 480 461 87
Totale 13.375